ERBB2 and breast cancer: [27] In fact, the importance of NK cell function is highlighted by the fact that there is a direct correlation between NK cell function and response to trastuzumab in metastatic HER2+ BC patients.[28] Preclinical models may not account for this, since many are conducted in vitro or in immunosuppressed models.